Advanced Accelerator Applications (AAA) is an innovative radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine, or MNM, products.
AAA is a European leader in the production and commercialization of molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT. These radiopharmaceuticals are mainly used for diagnosis in clinical oncology, cardiology and neurology.... more >
|Latest News||more >|
Advanced Accelerator Applications Signs Strategic Supply Agreement with University of Missouri for Lutetium 177
Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT® Launch Success
Advanced Accelerator Applications to Announce Full-Year 2016 Financial Results on March 23
|Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources|